MoonLake Immunotherapeutics (MLTX) Total Assets by Year
MoonLake Immunotherapeutics closed fiscal year 2025 with $424.4M in total assets, $120.0M in total liabilities and $304.5M in shareholder equity. This represents a decrease of 11.2% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters MoonLake Immunotherapeutics has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MLTX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
MLTX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $573.9M+24.7% | $400.4M-21.7% | $424.4M-11.2% | $414.3M-20.0% | $460.1M-15.6% | $511.3M-9.4% | $477.9M-9.2% | $518.2M+3.6% | $544.9M+7.6% | $564.1M+744.5% | $526.5M+585.2% | $500.2M+464.6% |
| Total Liabilities | $145.8M+42.7% | $146.3M+48.3% | $120.0M+388.8% | $123.1M+442.2% | $102.2M+588.1% | $98.7M+741.2% | $24.5M+88.1% | $22.7M+114.7% | $14.8M+97.7% | $11.7M-52.7% | $13.0M-53.3% | $10.6M-68.2% |
| Total Equity | $428.2M+21.1% | $254.0M-37.7% | $304.5M-31.9% | $288.9M-40.8% | $353.7M-32.1% | $407.5M-24.9% | $446.8M-9.9% | $488.2M+14.9% | $520.7M+6.3% | $542.6M+1191.8% | $495.7M+913.7% | $424.9M+668.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More MoonLake Immunotherapeutics financials
Frequently Asked Questions
What was MoonLake Immunotherapeutics's total assets in fiscal year 2025?
MoonLake Immunotherapeutics closed fiscal year 2025 with $424.4M in total assets, $120.0M in total liabilities and $304.5M in shareholder equity.
How fast is MoonLake Immunotherapeutics's total assets growing?
MoonLake Immunotherapeutics (MLTX) total assets fell by 11.2% year over year, from $477.9M to $424.4M in fiscal year 2025.
How has MoonLake Immunotherapeutics's total assets changed over the years?
Across the 5 fiscal years this page covers, MoonLake Immunotherapeutics (MLTX) total assets went from $9.7M in fiscal year 2021 to $424.4M in fiscal year 2025.
What was MoonLake Immunotherapeutics's total assets in the most recent quarter?
MoonLake Immunotherapeutics (MLTX) reported $573.9M in total assets in Q2 2026. This represents an increase of 24.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what MoonLake Immunotherapeutics (MLTX) reported on that line in every period on record.